Stay updated on BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial
Sign up to get notified when there's something new on the BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial page.

Latest updates to the BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial page
- Check2 days agoChange DetectedThe page now indicates that recruitment has ended by adding 'No longer looking for participants' and introduces new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). Additionally, a heading formatting change from 'Intervention / Treatment' to 'Intervention/Treatment' was applied and the revision footer updated to v3.6.0.SummaryDifference0.3%

- Check9 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5. This indicates a new version of the page was published, but no specific content changes are described in the changeset.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page’s revision indicator was updated from v3.5.3 to v3.5.4, reflecting a new revision of the page. This is a metadata update rather than a substantive change to study information.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a change to the site’s interface release rather than the underlying study details.SummaryDifference0.0%

- Check60 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.0%

- Check81 days agoChange DetectedFollicular lymphoma was added to the conditions section and the Genetic and Rare Diseases Information Center resources reference was included.SummaryDifference0.1%

Stay in the know with updates to BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial page.